{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:38:00Z","timestamp":1772847480848,"version":"3.50.1"},"reference-count":22,"publisher":"Microbiology Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"DOI":"10.1099\/jmm.0.028571-0","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T03:27:30Z","timestamp":1296790050000},"page":"1206-1212","source":"Crossref","is-referenced-by-count":29,"title":["Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile"],"prefix":"10.1099","volume":"60","author":[{"given":"Steliana","family":"Huhulescu","sequence":"first","affiliation":[{"name":"Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Sagel","sequence":"additional","affiliation":[{"name":"Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Fiedler","sequence":"additional","affiliation":[{"name":"Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Pecavar","sequence":"additional","affiliation":[{"name":"Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Blaschitz","sequence":"additional","affiliation":[{"name":"Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guenther","family":"Wewalka","sequence":"additional","affiliation":[{"name":"Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Allerberger","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Institute for Medical Microbiology, Hygiene and Infectious Diseases, Muellner Hauptstrasse 48, A-5020 Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Indra","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University, Institute for Medical Microbiology, Hygiene and Infectious Diseases, Muellner Hauptstrasse 48, A-5020 Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"r1","year":"2007","journal-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria"},{"key":"r2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/030006058801600410","article-title":"Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin","volume":"16","author":"Corazza","year":"1988","journal-title":"J Int Med Res"},{"key":"r3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1128\/JCM.32.7.1757-1762.1994","article-title":"Clinical impact of rapid in vitro susceptibility testing and bacterial identification","volume":"32","author":"Doern","year":"1994","journal-title":"J Clin Microbiol"},{"key":"r4","article-title":"Breakpoint tables for interpretation of MICs and zone diameters, Version 1.1","year":"2010"},{"key":"r5","first-page":"14","article-title":"Treatment of hepatic encephalopathy with non-absorbable antibiotics","volume":"24","author":"Festi","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47714-0"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2205-2206.2000"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2009.071688"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1086\/511870"},{"key":"r10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/JCM.29.1.33-37.1991","article-title":"Identification of toxigenic Clostridium difficile by the polymerase chain reaction","volume":"29","author":"Kato","year":"1991","journal-title":"J Clin Microbiol"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1999.tb13620.x"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00342-08"},{"key":"r13","first-page":"374","article-title":"Rifamycins","volume-title":"Antibiotic and Chemotherapy","author":"Parenti","year":"2003"},{"key":"r14","first-page":"245","article-title":"Susceptibility testing instrumentation and computerized expert systems for data analysis and interpretation","volume-title":"Manual of Clinical Microbiology","author":"Richter","year":"2007"},{"key":"r15","first-page":"483","article-title":"In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.","volume":"13","author":"Ripa","year":"1987","journal-title":"Drugs Exp Clin Res"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.9.3470-3475.2002"},{"key":"r17","first-page":"25","article-title":"The problem of resistance","volume-title":"Antibiotic and Chemotherapy","author":"Struelens","year":"2003"},{"key":"r18","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1128\/JCM.38.9.3209-3213.2000","article-title":"PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes","volume":"38","author":"Stubbs","year":"2000","journal-title":"J Clin Microbiol"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00047-06"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.3.1035-1041.2004"},{"key":"r21","first-page":"17","article-title":"Colidimin in neuer Packungsgr\u00f6\u00dfe","volume":"41","author":"Willerroider","year":"2009","journal-title":"Medical Tribune"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.1.43"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.028571-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T14:24:39Z","timestamp":1585923879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.028571-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.028571-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,1]]}}}